Bigtec Labs has bagged the Frost and Sullivan Award for the Product innovation. The award was for the development of the novel Micro Thermal Cycler Diagnostic Platform (MTCDP).
MTCDP can be used to diagnose hepatitis B and C. Efforts are also under way to recommend the product to be used for the detection of H1N1 virus. Its chip is based on BioMEMS and MEMS. The sensing element is a bio-molecule which is Deoxyribonucleic acid (DNA) based.
The battery operated portable miniaturized detection system could change the face of healthcare diagnostics in the country. It can find application anywhere from a remotely located primary health centre to an advanced hospital. The platform could also be used to conduct epidemiology studies to control epidemics. The data can be transferred to a central location for health analysts to collate the information of the epidemic for various purposes, stated GM Kini, managing director, Bigtec.
The Bangalore-based company has the know-how in Bio-MEMS, biochemistry, immunology, molecular biology, portable electronics, synthetic chemistry and assay development. Its revenue streams are from phase-I clinical trial software and hospital information systems. Its value added assignments are in the areas of bio-therapeutics, hand held point of care, clinical trial Phase I software for quality labs and drug discovery and development.
Frost & Sullivan GIL 2009 India event focusing on growth innovation and leadership was held in Bangalore. Kini along with G Sampathgiri, director, Deciphar Life Sciences, the wholly-owned subsidiary of Bigtec, a research informatics major received the Innovation Award.